Skip to main content
Terug
Watch Compare

UTAH MEDICAL PRODUCTS INC

Datakwaliteit: 100%
UTMD
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 65,47
▲ € 0,94 (1,45%)
Marktkapitalisatie: 209,73 M
Prijs
€ 65,47
Marktkapitalisatie
209,73 M
Dagbereik
€ 63,36 — € 65,47
52-Weeksbereik
€ 51,26 — € 68,71
Volume
7.162
Openen € 63,40
50D / 200D Gem.
€ 63,99
2,31% above
50D / 200D Gem.
€ 59,86
9,36% above

Quick Summary

Belangrijkste Punten

Revenue declined -5,86% annually over 5 years
Earnings declined -18,65% over the past year
Net margin of 29,30% shows strong profitability
Generating 14,32 M in free cash flow
Cash machine — converts 126,89% of earnings into free cash flow
Capital efficient — spends only 0,96% of revenue on capex

Groei

Revenue Growth (5Y)
-5,86%
Onder sectorgemiddelde (9,35%)
Revenue (1Y)-5,83%
Earnings (1Y)-18,65%
FCF Growth (3Y)-18,65%

Kwaliteit

Return on Equity
9,57%
Boven sectorgemiddelde (-51,02%)
ROIC7,68%
Net Margin29,30%
Op. Margin29,60%

Veiligheid

Debt / Equity
N/A
Current Ratio32,06
Interest CoverageN/A

Waardering

PE (TTM)
18,58
Boven sectorgemiddelde (-1,98)
P/B Ratio1,77
EV/EBITDA11,00
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E 18,6 -2,0
P/B 1,8 5,1
ROE % 9,6 -51,0
Net Margin % 29,3 -150,2
Rev Growth 5Y % -5,9 9,3
D/E — 0,3

ETFs Holding This Stock

DEEP logo DEEP Acquirers Small and Micro Deep Value ETF
1,04% weight
SQLV logo SQLV Royce Quant Small-Cap Quality Value ETF
0,20% weight
DES logo DES WisdomTree U.S. SmallCap Dividend Fund
0,06% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,02% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0,00% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight
AVUV logo AVUV Avantis U.S. Small Cap Value ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -5,83% Revenue Growth (3Y) -12,42%
Earnings Growth (1Y) -18,65% Earnings Growth (3Y) -17,63%
Revenue Growth (5Y) -5,86% Earnings Growth (5Y) -6,53%
Profitability
Revenue (TTM) 38,52 M Net Income (TTM) 11,29 M
ROE 9,57% ROA 9,30%
Gross Margin 57,12% Operating Margin 29,60%
Net Margin 29,30% Free Cash Flow (TTM) 14,32 M
ROIC 7,68% FCF Growth (3Y) -18,65%
Safety
Debt / Equity N/A Current Ratio 32,06
Interest Coverage N/A Asset Turnover 0,32
Working Capital 93,52 M Tangible Book Value 102,81 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 18,58 Forward P/E N/A
P/B Ratio 1,77 P/S Ratio 5,44
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 11,00 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 6,83%
Market Cap 209,73 M Enterprise Value 125,46 M
Per Share
EPS (Diluted TTM) 3,48 Revenue / Share 12,02
FCF / Share 4,47 OCF / Share 4,59
EPS CAGR (1Y) -12,12% EPS CAGR (5Y) -3,66%
EPS CAGR (10Y) 0,87%
Efficiency
CapEx / Revenue 0,96% FCF Conversion 126,89%
SBC-Adj. FCF 14,01 M Growth Momentum 0,03

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 38,52 M 40,90 M 50,22 M 52,28 M 49,05 M
Net Income 11,29 M 13,87 M 16,64 M 16,47 M 14,79 M
EPS (Diluted) 3,48 3,96 4,57 4,52 4,04
Gross Profit 22,00 M 24,14 M 30,04 M 32,20 M 30,92 M
Operating Income 11,40 M 13,59 M 16,78 M 19,79 M 18,88 M
EBITDA — — — — —
R&D Expenses 668.000,0 813.000,0 560.000,0 493.000,0 526.000,0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 2,82 M 2,93 M 3,45 M 4,19 M 4,27 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 122,54 M 122,54 M 135,46 M 123,87 M 115,64 M
Total Liabilities 3,27 M 5,11 M 7,15 M 9,62 M 8,50 M
Shareholders' Equity 119,27 M 117,43 M 128,31 M 114,25 M 107,14 M
Total Debt 0,0 0,0 0,0 0,0 0,0
Cash & Equivalents 85,76 M 82,98 M 92,87 M 75,05 M 60,97 M
Current Assets 97,74 M 96,33 M 106,27 M 89,92 M 73,16 M
Current Liabilities 2,60 M 3,76 M 4,71 M 5,96 M 3,75 M